永安药业
(002365)
| 流通市值：30.04亿 | | | 总市值：36.04亿 |
| 流通股本：2.46亿 | | | 总股本：2.95亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 225,069,433.67 | 201,456,204.04 | 253,213,751.54 | 230,585,726.41 |
| 交易性金融资产 | 588,231,257.15 | 634,575,149.1 | 622,768,814.05 | 687,885,327.94 |
| 应收票据及应收账款 | 243,281,156.37 | 195,101,785.12 | 154,888,162.49 | 122,816,396.29 |
| 其中：应收票据 | 142,274.42 | 507,854.42 | 1,300,077.97 | 5,980,717.37 |
| 应收账款 | 243,138,881.95 | 194,593,930.7 | 153,588,084.52 | 116,835,678.92 |
| 应收款项融资 | 12,014,778.85 | 12,957,182.35 | 7,958,428.98 | 2,152,013.64 |
| 预付款项 | 20,580,826.32 | 12,557,155.35 | 12,850,450.83 | 8,813,805.83 |
| 其他应收款合计 | 5,351,138.05 | 3,637,043.86 | 3,110,307.06 | 5,437,851.15 |
| 存货 | 109,964,086.64 | 100,908,964.39 | 78,974,280.04 | 90,892,788.12 |
| 其他流动资产 | 5,304,026.84 | 5,478,520.57 | 5,350,789.42 | 4,157,842.55 |
| 流动资产合计 | 1,209,796,703.89 | 1,166,672,004.78 | 1,139,114,984.41 | 1,152,741,751.93 |
| 非流动资产: | | | | |
| 长期股权投资 | 75,416,983.65 | 75,206,683.14 | 75,297,866.25 | 74,455,305.7 |
| 固定资产 | 838,598,292.48 | 861,362,460.05 | 835,543,566.9 | 859,783,604.44 |
| 在建工程 | 53,310,192.41 | 43,548,624.89 | 53,724,370.57 | 18,900,382.64 |
| 无形资产 | 74,240,959.96 | 75,097,936.74 | 75,959,914.32 | 76,821,891.9 |
| 递延所得税资产 | 4,893,768.24 | 3,682,193.39 | 11,860,831.85 | 11,410,902.47 |
| 其他非流动资产 | 44,908,222.72 | 2,852,041.11 | 3,717,269.8 | 6,547,752.02 |
| 非流动资产合计 | 1,091,368,419.46 | 1,061,749,939.32 | 1,056,103,819.69 | 1,047,919,839.17 |
| 资产总计 | 2,301,165,123.35 | 2,228,421,944.1 | 2,195,218,804.1 | 2,200,661,591.1 |
| 流动负债: | | | | |
| 短期借款 | 345,182.07 | 395,182.07 | 745,182.07 | 750,000 |
| 应付票据及应付账款 | 113,525,754.24 | 133,185,462.68 | 113,501,958.35 | 115,570,758.96 |
| 应付账款 | 113,525,754.24 | 133,185,462.68 | 113,501,958.35 | 115,570,758.96 |
| 合同负债 | 23,954,069.83 | 21,644,779.12 | 25,157,472.07 | 20,095,306.72 |
| 应付职工薪酬 | 47,267,743.98 | 36,747,441.84 | 26,158,625.23 | 36,103,443.98 |
| 应交税费 | 21,194,021.85 | 12,947,416.68 | 12,644,170.15 | 12,323,913.03 |
| 其他应付款合计 | 12,425,263.67 | 12,132,995.26 | 7,494,604.22 | 7,508,018.13 |
| 其他流动负债 | 5,007,245.59 | 5,253,103.63 | 5,654,234.52 | 11,583,781.54 |
| 流动负债合计 | 223,719,281.23 | 222,306,381.28 | 191,356,246.61 | 203,935,222.36 |
| 非流动负债: | | | | |
| 递延收益 | 7,821,031.96 | 8,314,841.48 | 8,796,984.34 | 9,284,960.53 |
| 递延所得税负债 | 1,198,594.23 | 1,207,954.31 | 4,354,777.22 | 5,501,770.17 |
| 非流动负债合计 | 9,019,626.19 | 9,522,795.79 | 13,151,761.56 | 14,786,730.7 |
| 负债合计 | 232,738,907.42 | 231,829,177.07 | 204,508,008.17 | 218,721,953.06 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 294,682,500 | 294,682,500 | 294,682,500 | 294,682,500 |
| 资本公积 | 722,296,494.36 | 722,296,494.36 | 722,296,494.36 | 722,296,494.36 |
| 减:库存股 | 40,475,988.99 | 40,475,988.99 | 40,475,988.99 | 40,475,988.99 |
| 其他综合收益 | 1,924,079.34 | 1,998,954.67 | 2,116,624.31 | 2,231,518.43 |
| 专项储备 | 31,071,023.39 | 29,875,874.22 | 29,686,975.72 | 28,789,636.43 |
| 盈余公积 | 148,676,496.29 | 148,676,496.29 | 148,676,496.29 | 148,676,496.29 |
| 未分配利润 | 916,322,568.89 | 845,301,417.04 | 838,544,341.3 | 830,807,637.84 |
| 归属于母公司股东权益合计 | 2,074,497,173.28 | 2,002,355,747.59 | 1,995,527,442.99 | 1,987,008,294.36 |
| 少数股东权益 | -6,070,957.35 | -5,762,980.56 | -4,816,647.06 | -5,068,656.32 |
| 股东权益合计 | 2,068,426,215.93 | 1,996,592,767.03 | 1,990,710,795.93 | 1,981,939,638.04 |
| 负债和股东权益合计 | 2,301,165,123.35 | 2,228,421,944.1 | 2,195,218,804.1 | 2,200,661,591.1 |
| 公告日期 | 2026-10-30 | 2026-08-28 | 2026-04-30 | 2026-04-17 |
| 审计意见(境内) | | | | 标准无保留意见 |